SCHEMBL4606583

SCHEMBL4606583

NC1CCCC1c1ccc(-c2ccc3c(c2)CCC3=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 5/20 0.52
CYP1A2 P05177 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PGR P06401 1/20 0.37
HRH3 Q9Y5N1 2/20 0.35
MAOB P27338 2/20 0.35
MAOA P21397 1/20 0.35
PRKCI P41743 1/20 0.35
KDM1A O60341 5/20 0.35
HDAC6 Q9UBN7 1/20 0.35
GRM5 P41594 1/20 0.35
PDE4D Q08499 1/20 0.34
PARP10 Q53GL7 1/20 0.34
PARP11 Q9NR21 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606578 0.82 HSD17B1 (0.51) HSD17B1CYP1A2CYP11B1CYP11B2CASP1
SCHEMBL28655414 0.75 HSD17B1 (0.78) HSD17B1CYP1A2CYP11B1CYP11B2CASP1
SCHEMBL4608530 0.74 GRIA4 (0.59) HSD17B1
SCHEMBL4606554 0.71 KDM1A (0.66) CYP1A2HSD17B10MAOBMAOAKDM1A
SCHEMBL1745161 0.71 HSD17B1 (0.71) HSD17B1CYP1A2CYP11B1CYP11B2CASP1
SCHEMBL1030949 0.70 HSD17B1 (1.00) HSD17B1CYP1A2CYP11B1CYP11B2CASP1
SCHEMBL30456099 0.70 HSD17B1 (0.65) HSD17B1CYP1A2CYP11B1CYP11B2CASP1
SCHEMBL1747435 0.70 HSD17B1 (0.69) HSD17B1CYP1A2CYP11B1CYP11B2CASP1
SCHEMBL28655417 0.70 HSD17B1 (0.65) HSD17B1CYP1A2CYP11B1CYP11B2CASP1
SCHEMBL1745120 0.70 HSD17B1 (0.69) HSD17B1CYP1A2CYP11B1CYP11B2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP claimed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US claimed
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP disclosed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US disclosed